Kangmei Pharma | 600518 - Pre Tax Profit

Stock Price
1.71
Daily Change
-0.02 -1.16%
Monthly
-3.39%
Yearly
-14.07%
Q2 Forecast
1.69

Kangmei Pharma reported CNY2.07M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Genomma Lab Internacional MXN 644.1M 76.04M Mar/2026
Hypermarcas BRL 439.21M 8.9M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
IQVIA Holdings USD 537M 5.62B Dec/2025
Jiangsu Hengrui CNY 2.56B 261.24M Mar/2026
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Moderna USD -187M 631M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Sh Fosun Pharma CNY 1.27B 155.78M Dec/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -7.9M 209.2M Sep/2025
Wuxi Apptec CNY 8.87B 3.84B Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025